Elbion

Radebeul, Germany Founded: 2002 • Age: 24 yrs Acquired By Biotie
Small molecules for CNS and inflammatory diseases were discovered.
Request Access

About Elbion

Elbion is a company based in Radebeul (Germany) founded in 2002 was acquired by Biotie in November 2008.. Elbion has raised $45 million across 1 funding round from investors including 3i Group, Biotie and Burrill and Company. Elbion has completed 1 acquisition, including DrugAbuse Sciences.

  • Headquarter Radebeul, Germany
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $45 M (USD)

    in 1 rounds

  • Latest Funding Round
    $45 M (USD), Series A

    Jan 10, 2005

  • Investors
    3i Group

    & 3 more

  • Employee Count
    Employee Count
  • Investments & Acquisitions
  • Acquired by
    Biotie

    (Nov 18, 2008)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Elbion

Elbion has successfully raised a total of $45M through 1 strategic funding round. The most recent funding activity was a Series A round of $45 million completed in January 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $45.0M
  • First Round

    (10 Jan 2005)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2005 Amount Series A - Elbion Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Elbion

Elbion has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include 3i Group, Biotie and Burrill and Company. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity firm focused on mid-market businesses
Founded Year Domain Location
Multi-category products are listed on an online B2B platform.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Elbion

Elbion has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include DrugAbuse Sciences. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Therapies for alcohol and drug addictions are developed and commercialized.
1994
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Elbion

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Elbion Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Elbion

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Elbion

Frequently Asked Questions about Elbion

When was Elbion founded?

Elbion was founded in 2002 and raised its 1st funding round 3 years after it was founded.

Where is Elbion located?

Elbion is headquartered in Radebeul, Germany. It is registered at Radebeul, Saxony, Germany.

Is Elbion a funded company?

Elbion is a funded company, having raised a total of $45M across 1 funding round to date. The company's 1st funding round was a Series A of $45M, raised on Jan 10, 2005.

What does Elbion do?

Elbion was focussed on the discovery of small molecules against inflammatory and CNS diseases. Its drug discovery activities were focused on PDE inhibitors, adenosine antagonists and potassium channel modulators. It was co-developing its lead product, AWD 12-281 along with GSK for COPD and for atopic dermatitis. It was also developing ELB139, a subunit-specific GABA(A) agonist for the anxiety disorders and ELB353 for inflammatory diseases. In October 2008, Biotie acquired Elbion.

How many acquisitions has Elbion made?

Elbion has made 1 acquisition, including DrugAbuse Sciences.

Who are Elbion's investors?

Elbion has 4 investors. Key investors include 3i Group, Biotie, Burrill and Company, and Deutsche Venture Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available